Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Deficit [Member]
Balances at beginning at Dec. 31, 2023	$ 157,507	$ 32	$ 433,885		$ (276,410)
Balances at beginning (shares) at Dec. 31, 2023		31,678,159
Stock-based compensation	6,445		6,445
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units	15		15
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units (shares)		14,034
Exercise of common stock warrants and pre-funded common stock warrants	923	$ 1	922
Exercise of common stock warrants and pre-funded common stock warrants (shares)		1,644,886
Unrealized loss on marketable securities	(105)			$ (105)
Foreign currency translation adjustment	(1)			(1)
Net loss	(21,398)				(21,398)
Balances at ending at Mar. 31, 2024	143,386	$ 33	441,267	(106)	(297,808)
Balances at end (shares) at Mar. 31, 2024		33,337,079
Balances at beginning at Dec. 31, 2024	245,113	$ 46	696,966	361	(452,260)
Balances at beginning (shares) at Dec. 31, 2024		45,703,811
Stock-based compensation	14,679		14,679
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units	13,366	$ 1	13,365
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units (shares)		943,980
Exercise of common stock warrants	3,011	$ 2	3,009
Exercise of common stock warrants (shares)		1,879,678
Unrealized loss on marketable securities	(139)			(139)
Foreign currency translation adjustment	4			4
Net loss	(43,773)				(43,773)
Balances at ending at Mar. 31, 2025	$ 232,261	$ 49	$ 728,019	$ 226	$ (496,033)
Balances at end (shares) at Mar. 31, 2025		48,527,469